查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1439131

血液製備市場 - 2018-2028 年全球產業規模、佔有率、趨勢、機會和預測，按產品、類型、按應用區域和競爭細分

Blood Preparation Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Product, By Type, By Application Region and Competition
出版日期: | 出版商: TechSci Research | 英文 182 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2022 年全球血液製備市場估值為 391.2 億美元，預計在預測期內將強勁成長，到 2028 年CAGR為 5.74%。全球血液製備市場是醫療保健和製藥行業動態且重要的組成部分，涵蓋廣泛的產品和服務，旨在確保各種醫療應用的血液和血液相關產品的可用性和安全性。該市場圍繞著血液成分、血漿和其他血液衍生物的加工、測試和分銷，這對於挽救生命的輸血、治療和研究至關重要。隨著對病人安全的日益重視，對先進、高品質的血液製備產品和服務的需求不斷增加。

市場概況
預測期 2024-2028
2022 年市場規模 391.2億美元
2028 年市場規模 546.5億美元
2023-2028 年CAGR 5.74%
成長最快的細分市場 血液衍生物
最大的市場 北美洲

該市場的主要驅動力之一是慢性疾病盛行率的上升，這需要頻繁的輸血。貧血、癌症和血液疾病等疾病需要穩定的血液製品供應，這推動了對高效血液製備和儲存解決方案的需求。此外，全球人口老化導致對血液製劑的需求不斷增加，因為老年人更有可能需要輸血。

血液製備技術的創新和自動化的採用顯著提高了血液製備過程的效率和安全性，並降低了輸血相關併發症的風險。此外，嚴格的法規和品質標準使得整個血液製備鏈更注重安全措施和品質保證。這些因素導致該領域的研究和開發活動激增，從而引入了新的和改進的血液製備方法和產品。

主要市場促進因素

慢性病的盛行率

目錄

第 1 章：產品概述

第 2 章：研究方法

第 3 章：執行摘要

第 4 章：全球血液製備市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依產品（全血、血液成分、血液衍生物）
    • 按類型（血小板聚集抑制劑、纖溶劑、抗凝血劑）
    • 按應用（血小板增多症、肺栓塞、腎功能損害、心絞痛血管併發症、其他）
    • 按地區
    • 按公司分類 (2022)
  • 市場地圖
    • 按產品分類
    • 按類型
    • 按應用
    • 按地區

第 5 章：亞太地區血液製劑市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按產品分類
    • 按類型
    • 按應用
    • 按國家/地區
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 澳洲
    • 日本
    • 韓國

第 6 章：歐洲血液製劑市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按產品分類
    • 按類型
    • 按應用
    • 按國家/地區
  • 歐洲：國家分析
    • 法國
    • 德國
    • 西班牙
    • 義大利
    • 英國

第 7 章：北美血液製備市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按產品分類
    • 按治療
    • 按應用
    • 按國家/地區
  • 北美：國家分析
    • 美國
    • 墨西哥
    • 加拿大

第 8 章：南美洲血液製劑市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按產品分類
    • 按類型
    • 按應用
    • 按國家/地區
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第 9 章：中東和非洲血液製劑市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按產品分類
    • 按類型
    • 按應用
    • 按國家/地區
  • MEA：國家分析
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 10 章：市場動態

  • 促進要素
  • 挑戰

第 11 章：市場趨勢與發展

  • 最近的發展
  • 產品發布
  • 併購

第 12 章：全球血液製備市場：SWOT 分析

第 13 章：波特的五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 客戶的力量
  • 替代產品的威脅

第14章：競爭格局

  • Pfizer, Inc.
  • Bristol-Myers Squibb Company
  • Leo Pharma A/S
  • Sanofi
  • Xiamen Hisunny Chemical Co., LTD
  • AstraZeneca plc
  • Baxter International Inc
  • Portola Pharmaceuticals, Inc.
  • GlaxoSmithKline PLC
  • Shandong East Chemical Industry Co.

第 15 章：策略建議

第16章調查會社について,免責事項

簡介目錄
Product Code: 20728

Global Blood Preparation Market was valued at USD 39.12 billion in 2022 and is anticipated to project robust growth in the forecast period with a CAGR of 5.74% through 2028. The Global Blood Preparation Market is a dynamic and critical component of the healthcare and pharmaceutical industry, encompassing a wide range of products and services aimed at ensuring the availability and safety of blood and blood-related products for various medical applications. This market revolves around the processing, testing, and distribution of blood components, plasma, and other blood derivatives, vital for life-saving transfusions, therapeutic treatments, and research. With a growing emphasis on patient safety, the demand for advanced and high-quality blood preparation products and services has been steadily increasing.

Market Overview
Forecast Period2024-2028
Market Size 2022USD 39.12 Billion
Market Size 2028USD 54.65 Billion
CAGR 2023-20285.74%
Fastest Growing SegmentBlood Derivatives
Largest MarketNorth America

One of the primary drivers of this market is the rising prevalence of chronic diseases, which necessitate frequent blood transfusions. Conditions such as anemia, cancer, and blood disorders require a stable supply of blood products, driving the demand for efficient blood preparation and storage solutions. Additionally, the global aging population contributes to the increasing need for blood preparations as older individuals are more likely to require transfusions.

Innovations in blood preparation technologies and the adoption of automation have significantly enhanced the efficiency and safety of the blood preparation process, reducing the risk of transfusion-related complications. Moreover, stringent regulations and quality standards have led to a greater focus on safety measures and quality assurance throughout the blood preparation chain. These factors have led to a surge in research and development activities in the field, resulting in the introduction of new and improved blood preparation methods and products.

Key Market Drivers

Prevalence of Chronic Diseases

The prevalence of chronic diseases is a primary driver behind the rapid growth of the Global Blood Preparation Market. Chronic diseases, which encompass a wide range of conditions such as cancer, anemia, hemophilia, and blood disorders, often necessitate frequent blood transfusions as an integral part of their management and treatment. This demand for blood and blood-related products is escalating due to the increasing global burden of chronic diseases.

As populations age and lifestyles become increasingly sedentary, the incidence of chronic diseases continues to rise. Conditions like diabetes, cardiovascular diseases, and cancer have become more common, leading to a growing need for blood preparations. For instance, cancer patients often require regular blood transfusions to manage the anemia and low platelet counts associated with chemotherapy, while individuals with blood disorders like sickle cell anemia depend on blood transfusions to alleviate their symptoms and complications.

In addition to the aging population and sedentary lifestyles, other factors like environmental pollution and dietary habits also contribute to the rise in chronic diseases. As these conditions become more prevalent, the demand for blood products, including red blood cells, platelets, and plasma, remains high. This places significant importance on the efficient and safe preparation of these life-saving products, further driving the growth of the global blood preparation market.

Healthcare systems and blood banks around the world are continually striving to meet this increasing demand by investing in state-of-the-art blood preparation technologies and stringent quality control measures. Consequently, the global blood preparation market is not only expanding but also evolving to cater to the unique requirements of chronic disease patients. In conclusion, the growing prevalence of chronic diseases is a pivotal factor propelling the global blood preparation market, emphasizing the market's essential role in ensuring a stable and safe supply of blood and blood-related products for the management and treatment of these conditions.

Rise in Surgical Procedures

The Global Blood Preparation Market is experiencing significant growth, and one of the key driving factors behind this expansion is the rise in surgical procedures. Surgical interventions, whether elective or emergency, often necessitate blood transfusions to manage bleeding disorders, replace lost blood, or support patients with various medical conditions. As the global population continues to grow, and healthcare access improves, there has been a corresponding increase in the number of surgical procedures conducted worldwide, thereby fueling the demand for blood preparation products and services.

Surgical procedures encompass a wide range of medical interventions, including cardiac surgeries, organ transplants, trauma surgeries, and orthopedic surgeries, among others. These surgeries may be complex, lengthy, or involve significant blood loss, necessitating the availability of safe and ready-to-use blood products.

Patients undergoing major surgeries may require red blood cell transfusions to correct anemia or platelet transfusions to manage excessive bleeding. In emergency surgeries, quick access to blood preparations is vital to address unforeseen complications or blood loss. Thus, the global blood preparation market plays an indispensable role in providing a stable supply of blood components and products, which are crucial for the success and safety of surgical procedures.

In addition to the growing demand for surgical procedures, advancements in surgical techniques and medical technologies are contributing to the expansion of the blood preparation market. Minimally invasive procedures, robotic-assisted surgeries, and improved perioperative care have resulted in more patients undergoing surgery, even those with preexisting medical conditions. This, in turn, increases the need for blood preparations as a safety net during complex surgeries.

Advancements in Blood Testing and Screening

Advancements in blood testing and screening have emerged as a vital driver behind the growth of the Global Blood Preparation Market. Blood safety is of paramount importance in healthcare, and innovations in testing and screening technologies have significantly improved the quality and reliability of blood preparations, thereby increasing the demand for these products and services.

Modern blood testing and screening techniques have become more accurate, efficient, and comprehensive, enabling healthcare professionals to detect a wider array of infectious agents, bloodborne pathogens, and diseases. These technological advancements have enhanced the safety of blood products, reducing the risk of transfusion-related complications and ensuring that patients receive safer and more effective treatments.

One of the most notable advancements in blood testing and screening is the development of nucleic acid testing (NAT), which allows for the highly sensitive detection of viruses such as HIV, hepatitis B and C, and others. NAT technology has significantly reduced the window period during which infections may be undetectable, enhancing the overall safety of the blood supply.

Furthermore, automation in blood testing has streamlined the process, reduced human error and enhancing the accuracy of test results. Automated systems are capable of processing large volumes of blood samples efficiently, making high-throughput screening possible. This ensures a faster turnaround time for test results and a more reliable supply of safe blood preparations.

The importance of these advancements in blood testing and screening is underscored by the increasing regulatory standards and stringent quality control measures imposed by health authorities worldwide. To meet these elevated standards, healthcare providers and blood banks are investing in the latest testing and screening technologies, driving the growth of the blood preparation market.

Key Market Challenges

Stringent Regulatory Compliance

The Global Blood Preparation Market, a crucial pillar of healthcare, faces a formidable challenge in the form of stringent regulatory compliance. While regulations are essential to ensuring the safety and efficacy of blood and blood-related products, the stringent nature of these requirements can impede the market's growth and operational efficiency.

Blood preparation involves a complex set of processes, from collection and testing to storage and distribution. Regulatory bodies, such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), set stringent standards that must be met to guarantee the safety and quality of blood products. These standards encompass numerous facets of the blood preparation process, including donor eligibility criteria, testing protocols, documentation, and the maintenance of storage and transportation conditions.

Meeting these rigorous regulatory requirements can be a resource-intensive endeavor, particularly for smaller blood banks and healthcare providers. Compliance demands substantial investments in state-of-the-art equipment, quality control measures, staff training, and infrastructure. These expenses can be cost-prohibitive for smaller organizations, potentially limiting their ability to participate in the market. Furthermore, the constant need to adapt to evolving regulations places an ongoing financial burden on stakeholders within the blood preparation industry.

Safety Concerns and Infectious Diseases

The Global Blood Preparation Market is a cornerstone of modern healthcare, providing a vital supply of blood and blood-related products for various medical applications. However, this market faces a significant challenge in the form of safety concerns related to infectious diseases. Despite rigorous testing and screening protocols, the risk of transmitting infections through blood products remains, hindering the market's growth and raising public safety concerns.

Ensuring the safety of blood and blood-related products is a primary focus of healthcare systems and regulatory bodies around the world. Bloodborne pathogens such as HIV, hepatitis B and C, and emerging infectious diseases pose a continuous threat. Despite remarkable advances in blood testing and screening technologies, the inherent risk of transmission, though minimal, persists.

Infectious diseases can be transmitted through blood products, especially in cases where donors may be in the early stages of an infection or the causative agent may be less detectable. While the chances of transmission are exceedingly rare, the very possibility raises safety concerns among the public, impacting trust in blood transfusion services and potentially discouraging potential blood donors.

Outbreaks of emerging infectious diseases, such as Zika virus and the novel coronavirus (SARS-CoV-2), have highlighted the ongoing challenges in ensuring blood safety. During such outbreaks, there is an urgent need to implement additional screening measures and donor deferral policies, which can strain the resources of blood banks and create logistical challenges.

Key Market Trends

Technological Advancements in Blood Preparation

Technological advancements in blood preparation are playing a pivotal role in boosting the Global Blood Preparation Market. Automation, sophisticated equipment, and innovative methods have ushered in a new era of efficiency, safety, and quality within the industry. These advancements are reshaping the landscape of blood collection, processing, and storage, leading to an enhanced market with numerous benefits for healthcare providers and patients alike.

Automation, in particular, stands out as a game-changer in the field. Automated blood preparation systems have revolutionized the industry by significantly reducing human error, enhancing precision, and accelerating the speed at which blood components can be prepared. Automated equipment can process large volumes of blood with unmatched precision, resulting in a more consistent and reliable supply of blood products. This not only improves operational efficiency but also reduces the margin of error, ensuring that the final products meet the highest quality and safety standards.

Moreover, innovative methods and technologies have paved the way for more advanced testing and screening processes. The introduction of nucleic acid testing (NAT), for instance, has significantly enhanced the sensitivity and accuracy of detecting infectious agents, such as HIV, hepatitis B and C. This improvement in blood safety has instilled greater confidence among healthcare professionals and the public, reassuring them that blood products are less likely to transmit infections or other complications.

Additionally, technology has enabled blood banks and healthcare providers to optimize their processes to meet the growing demand for blood derivatives, such as plasma and platelets. These components are vital for various medical treatments, and advancements in blood preparation methods cater to the specific requirements of these products, allowing for their efficient production and delivery.

Demand for Blood Derivatives

The growing demand for blood derivatives is a significant driver behind the expansion of the Global Blood Preparation Market. While whole blood and red blood cells remain essential, the rising demand for specific blood derivatives, such as plasma and platelets, has emerged as a notable trend that is reshaping the industry.

Blood derivatives, distinct from whole blood, provide a concentrated source of specific blood components, making them indispensable for a wide range of medical treatments. These specialized components play a crucial role in managing clotting disorders, immune disorders, and are vital in the development of cutting-edge therapies and treatments. Their versatility and effectiveness in various medical applications have fueled a surge in demand, propelling the blood preparation market to adapt and evolve.

Plasma is rich in clotting factors and antibodies, making it a cornerstone in the treatment of patients with bleeding disorders and autoimmune diseases. Additionally, plasma-derived products are fundamental in the production of critical therapies, including immunoglobulins and coagulation factors, which are vital for individuals with immune deficiencies or hemophilia.

Platelets, on the other hand, are essential for proper blood clotting and are frequently used in the management of patients undergoing chemotherapy, those with bone marrow disorders, and individuals with impaired platelet function. The demand for platelets is on the rise, as they are indispensable for patients undergoing complex surgical procedures, such as organ transplants or cardiac surgeries.

The growth in the demand for these blood derivatives has prompted blood banks and healthcare providers to optimize their blood preparation processes to cater to these specific requirements efficiently. This trend is not only driven by the need for these components but also by advances in medical science and the development of innovative therapies that rely on these specialized blood products.

Segmental Insights

Product Insights

Based on the Product, Blood Preparation devices emerged as the dominant segment in the global market for Global Blood Preparation Market in 2022. Blood components offer a high degree of flexibility and are suitable for a wide range of medical conditions and treatments. Unlike whole blood, which includes all blood components, blood components can be tailored to meet the specific needs of patients. For example, red blood cells can be transfused to address anemia, platelets are essential for clotting disorders, and plasma is used for various therapeutic purposes. This flexibility makes blood components highly sought after as they can be used in diverse clinical situations. Blood components are essential for specialized medical treatments and therapies. The development of innovative treatments and therapies that rely on these specialized blood products further drives the demand for blood components.

Type Insights

Based on the Type, the Anticoagulants segment emerged as the dominant player in the global market for Global Blood Preparation Market in 2022. Anticoagulants are particularly crucial in preventing and managing thrombosis, which is the formation of dangerous blood clots in the blood vessels. Conditions such as DVT and PE can be life-threatening if left untreated. Anticoagulants help reduce the risk of clot formation and embolism, ultimately saving lives. Anticoagulants are available in various formulations, allowing healthcare providers to select the most suitable option for their patients. These formulations include oral anticoagulants (e.g., warfarin and direct oral anticoagulants), injectable heparin derivatives, and low-molecular-weight heparins, providing flexibility in treatment choices.

Regional Insights

North America emerged as the dominant player in the global Blood Preparation Market in 2022, holding the largest market share. North America boasts a highly advanced and well-established healthcare infrastructure. The region is equipped with state-of-the-art medical facilities, blood banks, and healthcare institutions that rely heavily on blood preparation products to support a wide range of medical procedures, from surgeries to cancer treatments. North America has some of the most stringent regulatory standards for blood preparation and transfusion safety. Regulatory authorities like the U.S. Food and Drug Administration (FDA) and the Canadian Blood Services maintain rigorous oversight of blood product safety, driving the demand for high-quality blood preparation products that meet these standards.

Key Market Players

Pfizer, Inc.

Bristol-Myers Squibb Company

Leo Pharma A/S

Sanofi

Xiamen Hisunny Chemical Co., LTD

AstraZeneca plc

Baxter International Inc

Portola Pharmaceuticals, Inc.

GlaxoSmithKline PLC

Shandong East Chemical Industry Co.

Report Scope:

In this report, the Global Blood Preparation Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Global Blood Preparation Market, By Product:

  • Whole Blood
  • Blood Components
  • Blood Derivatives

Global Blood Preparation Market, By Type:

  • Platelet Aggregation Inhibitors
  • Fibrinolytics
  • Anticoagulants

Global Blood Preparation Market, By Application:

  • Thrombocytosis
  • Pulmonary Embolism
  • Renal Impairment
  • Angina Blood Vessel Complications
  • Others

Global Blood Preparation Market, By Region:

  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
  • Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

  • Company Profiles: Detailed analysis of the major companies present in the Global Blood Preparation Market.

Available Customizations:

  • Global Blood Preparation Market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Global Blood Preparation Market Outlook

  • 4.1. Market Size & Forecast
    • 4.1.1. By Value
  • 4.2. Market Share & Forecast
    • 4.2.1. By Product (Whole Blood, Blood Components, Blood Derivatives)
    • 4.2.2. By Type (Platelet Aggregation Inhibitors, Fibrinolytics, Anticoagulants)
    • 4.2.3. By Application (Thrombocytosis, Pulmonary Embolism, Renal Impairment, Angina Blood Vessel Complications, Others)
    • 4.2.4. By Region
    • 4.2.5. By Company (2022)
  • 4.3. Market Map
    • 4.3.1. By Product
    • 4.3.2. By Type
    • 4.3.3. By Application
    • 4.3.4. By Region

5. Asia Pacific Blood Preparation Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product
    • 5.2.2. By Type
    • 5.2.3. By Application
    • 5.2.4. By Country
  • 5.3. Asia Pacific: Country Analysis
    • 5.3.1. China Blood Preparation Market Outlook
      • 5.3.1.1. Market Size & Forecast
        • 5.3.1.1.1. By Value
      • 5.3.1.2. Market Share & Forecast
        • 5.3.1.2.1. By Product
        • 5.3.1.2.2. By Type
        • 5.3.1.2.3. By Application
    • 5.3.2. India Blood Preparation Market Outlook
      • 5.3.2.1. Market Size & Forecast
        • 5.3.2.1.1. By Value
      • 5.3.2.2. Market Share & Forecast
        • 5.3.2.2.1. By Product
        • 5.3.2.2.2. By Type
        • 5.3.2.2.3. By Application
    • 5.3.3. Australia Blood Preparation Market Outlook
      • 5.3.3.1. Market Size & Forecast
        • 5.3.3.1.1. By Value
      • 5.3.3.2. Market Share & Forecast
        • 5.3.3.2.1. By Product
        • 5.3.3.2.2. By Type
        • 5.3.3.2.3. By Application
    • 5.3.4. Japan Blood Preparation Market Outlook
      • 5.3.4.1. Market Size & Forecast
        • 5.3.4.1.1. By Value
      • 5.3.4.2. Market Share & Forecast
        • 5.3.4.2.1. By Product
        • 5.3.4.2.2. By Type
        • 5.3.4.2.3. By Application
    • 5.3.5. South Korea Blood Preparation Market Outlook
      • 5.3.5.1. Market Size & Forecast
        • 5.3.5.1.1. By Value
      • 5.3.5.2. Market Share & Forecast
        • 5.3.5.2.1. By Product
        • 5.3.5.2.2. By Type
        • 5.3.5.2.3. By Application

6. Europe Blood Preparation Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Type
    • 6.2.3. By Application
    • 6.2.4. By Country
  • 6.3. Europe: Country Analysis
    • 6.3.1. France Blood Preparation Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Type
        • 6.3.1.2.3. By Application
    • 6.3.2. Germany Blood Preparation Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Type
        • 6.3.2.2.3. By Application
    • 6.3.3. Spain Blood Preparation Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Type
        • 6.3.3.2.3. By Application
    • 6.3.4. Italy Blood Preparation Market Outlook
      • 6.3.4.1. Market Size & Forecast
        • 6.3.4.1.1. By Value
      • 6.3.4.2. Market Share & Forecast
        • 6.3.4.2.1. By Product
        • 6.3.4.2.2. By Type
        • 6.3.4.2.3. By Application
    • 6.3.5. United Kingdom Blood Preparation Market Outlook
      • 6.3.5.1. Market Size & Forecast
        • 6.3.5.1.1. By Value
      • 6.3.5.2. Market Share & Forecast
        • 6.3.5.2.1. By Product
        • 6.3.5.2.2. By Type
        • 6.3.5.2.3. By Application

7. North America Blood Preparation Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Treatment
    • 7.2.3. By Application
    • 7.2.4. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Blood Preparation Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Type
        • 7.3.1.2.3. By Application
    • 7.3.2. Mexico Blood Preparation Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Type
        • 7.3.2.2.3. By Application
    • 7.3.3. Canada Blood Preparation Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Type
        • 7.3.3.2.3. By Application

8. South America Blood Preparation Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Type
    • 8.2.3. By Application
    • 8.2.4. By Country
  • 8.3. South America: Country Analysis
    • 8.3.1. Brazil Blood Preparation Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Type
        • 8.3.1.2.3. By Application
    • 8.3.2. Argentina Blood Preparation Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Type
        • 8.3.2.2.3. By Application
    • 8.3.3. Colombia Blood Preparation Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Type
        • 8.3.3.2.3. By Application

9. Middle East and Africa Blood Preparation Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Type
    • 9.2.3. By Application
    • 9.2.4. By Country
  • 9.3. MEA: Country Analysis
    • 9.3.1. South Africa Blood Preparation Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Type
        • 9.3.1.2.3. By Application
    • 9.3.2. Saudi Arabia Blood Preparation Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Type
        • 9.3.2.2.3. By Application
    • 9.3.3. UAE Blood Preparation Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Type
        • 9.3.3.2.3. By Application

10. Market Dynamics

  • 10.1. Drivers
  • 10.2. Challenges

11. Market Trends & Developments

  • 11.1. Recent Developments
  • 11.2. Product Launches
  • 11.3. Mergers & Acquisitions

12. Global Blood Preparation Market: SWOT Analysis

13. Porter's Five Forces Analysis

  • 13.1. Competition in the Industry
  • 13.2. Potential of New Entrants
  • 13.3. Power of Suppliers
  • 13.4. Power of Customers
  • 13.5. Threat of Substitute Product

14. Competitive Landscape

  • 14.1. Pfizer, Inc.
    • 14.1.1. Business Overview
    • 14.1.2. Company Snapshot
    • 14.1.3. Products & Services
    • 14.1.4. Current Capacity Analysis
    • 14.1.5. Financials (In case of listed)
    • 14.1.6. Recent Developments
    • 14.1.7. SWOT Analysis
  • 14.2. Bristol-Myers Squibb Company
  • 14.3. Leo Pharma A/S
  • 14.4. Sanofi
  • 14.5. Xiamen Hisunny Chemical Co., LTD
  • 14.6. AstraZeneca plc
  • 14.7. Baxter International Inc
  • 14.8. Portola Pharmaceuticals, Inc.
  • 14.9. GlaxoSmithKline PLC
  • 14.10. Shandong East Chemical Industry Co.

15. Strategic Recommendations

16. About Us & Disclaimer